Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 GBX | -5.41% | -9.68% | -70.21% |
20/05 | IQ-AI subsidiary gets second FDA rare paediatric disease designation | AN |
20/05 | IQ-AI's Imaging Biometrics Gets Second Rare Disease Designation for Drug Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-70.21% | 41.69L | |
-17.05% | 855.16Cr | |
+68.22% | 424.44Cr | |
-1.63% | 252.8Cr | |
-9.63% | 243.72Cr | |
-38.23% | 234.52Cr | |
-7.85% | 189.01Cr | |
-17.74% | 155.21Cr | |
-39.48% | 123.34Cr | |
+9.68% | 113.19Cr |
- Stock Market
- Equities
- IQAI Stock
- News IQ-AI Limited
- IQ-AI Plans Share Placing to Advance Oral Anti-tumor Agent Development